| Acute Leukemia |
1 |
1 |
| Genomic Medicine |
0 |
0.77 |
| Leukemia |
0 |
0.66 |
| Child |
0 |
0.52 |
| Genetic Testing |
0 |
0.98 |
| Biologic Therapy |
0 |
0.43 |
| Stem Cell Research and Therapy |
0 |
0.42 |
| Genetics |
0 |
0.41 |
| Acute Myeloblastic Leukemia |
0 |
0.99 |
| Chemotherapy |
0 |
0.31 |
| Bone Marrow Transplant |
0 |
0.24 |
| Transplantation |
0 |
0.24 |
| Allogeneic stem cell transplant |
0 |
0.22 |
| Cell Transplantation |
0 |
0.22 |
| Cancer |
0 |
0.21 |
| Targeted Cancer Therapy |
0 |
0.21 |
| Healthcare and Medical Technology |
0 |
0.18 |
| Clinical Research |
0 |
0.17 |
| Bone Marrow |
0 |
0.15 |
| Hospital |
0 |
0.14 |
| Remission |
0 |
0.14 |
| Bone |
0 |
0.1 |
| Quality of Life |
0 |
0.1 |
| Hodgkin Lymphoma |
0 |
0.09 |
| Blood |
0 |
0.07 |
| Hematology |
0 |
0.07 |
| Lymphoma |
0 |
0.07 |
| Prognosis |
0 |
0.07 |